An Open-Label Study to Evaluate the Effect of Every Other Week PROCRITï¿½ (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)